
HiQ-Nano
Manufacturing precisely engineered and highly characterized “green” nanomaterials for a wide range of applications.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | Support Program | ||
Total Funding | 000k |
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 334 % | 71 % | (20 %) | 64 % | (25 %) | - | - |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (353 %) | 121 % | 57 % | (244 %) | - | - | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (387 %) | 89 % | 25 % | (289 %) | 1 % | - | - |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
HiQ-Nano operates as a specialized manufacturer of nanomaterials, originating as a spin-off from the Italian Institute of Technology (IIT). Founded in 2013 by Pier Paolo Pompa and Maria Ada Malvindi, the company leverages the extensive scientific background of its team, which is composed of PhD scientists with multidisciplinary expertise in nanofabrication, nanobiotechnology, and material science. The founders' journey involved overcoming challenges in obtaining high-quality nanoparticles with defined characteristics during their scientific careers, leading to the development of new synthetic routes and advanced characterization techniques.
The company's core business is the design, fabrication, and characterization of high-quality, precisely engineered nanoparticles. HiQ-Nano serves both academic research institutions and industrial clients by providing highly monodispersed and stable nanoparticles with low batch-to-batch variability. Its business model centers on the sale of these advanced materials. Each batch of nanoparticles undergoes rigorous characterization for shape, size distribution, charge, and agglomeration state using state-of-the-art techniques like Transmission Electron Microscopy (TEM) and Dynamic Light Scattering (DLS).
The product portfolio includes a variety of nanoparticles such as fluorescent nanobeads, gold and silver nanoparticles, and various forms of silica nanoparticles, including mesoporous silica with high surface area. These materials are designed for a wide range of applications, with a particular focus on point-of-care diagnostics, home testing, and colorimetric assays. The company emphasizes the production of "green" nanomaterials and has received funding through various grants and from investors including the European Union, MITO Technology, and Progress Tech Transfer.
Keywords: nanoparticles, nanomaterials, nanobiotechnology, nanofabrication, material science, Italian Institute of Technology spin-off, point-of-care diagnostics, colorimetric assays, gold nanoparticles, silica nanoparticles, fluorescent nanobeads, Pier Paolo Pompa, Maria Ada Malvindi, particle characterization, nanomedicine, drug delivery, biosensors, academic research materials, industrial nanotechnology, monodispersed nanoparticles